HEAL vs HELX: Holdings Overlap & Returns
Over the year to Nov 13, 2026, HEAL returned +0.2% to HELX's +22.6%; 3% of their weight is in the same names.
- Return gap
- +22.4 pts1 year to Nov 13, 2026: HELX ahead, total return
- Fee gap
- 0.00 ptsA year: both 0.50%, per filings dated Mar 27, 2026 and Jul 27, 2026
- Overlap
- 3%Share of the two books held in common, holdings dated Nov 11, 2026 and Jun 30, 2026
- Net flow
- –Needs daily flows for both funds
Compare two other funds
Growth of 100
Drawn from the numbers on this page. Growth of 100, both funds, distributions reinvested
HEAL +0.2%, HELX +22.6%: HELX +22.4 pts ahead, 1 year, Nov 13, 2025 to Nov 13, 2026.
ShareUse this comparison
Cost to trade
Hypothetical. A $10,000 order in HEAL costs about $33.00 one way and $66.00 in and out, at a median spread of 0.66%. The 0.66% spread is HEAL’s 30-day median, from Global X (fund page).
Fees over time
Hypothetical. $10,000 in HEAL for 10 years at 0.50% a year costs about $827 in fees and lost growth; HELX at 0.50% would cost $827. Assumes 6% a year before fees, a sample rate, not a forecast.
How each fund moved
27% of HEAL's weight is in S&P 500 companies and 73% is outside the index. Holdings as of Nov 11, 2026.
15% of HELX's weight is in S&P 500 companies and 85% is outside the index. Holdings as of Jun 30, 2026.
Key numbers
Both cost 0.50% a year; their one-year returns differ by 22.4 points; HEAL is 1.1 times larger.
Pair scorecard
Open the table
Points (pts) are percentage points.
| Total return, 1 year | +0.2% | +22.6% |
|---|---|---|
| Below its all-time high | 55.5%, high on Feb 12, 2021 | 26.5%, high on Sep 7, 2021 |
| What it tracks | Healthcare innovation and GLP-1 | Healthcare innovation and GLP-1 |
| Expense ratio | 0.50% | 0.50% |
| Net assets, as of Nov 11, 2026 | $38m | $35m |
| Holdings in common | 3% |
The numbers behind it
Net assets: $38m on Nov 11, 2026 for Global X HealthTech ETF, and $34m on Nov 12, 2026 for Franklin Genomic Advancements ETF.
Holdings in common uses holdings dated Jun 30, 2026 and Nov 11, 2026.
What they share
By the books each fund has filed, HEAL and HELX hold 3% of their money in the same securities at the same weight. Holdings dated Jun 30, 2026 and Nov 11, 2026.
half
3% in common
Held in common
Show all 4 holdings
| TEMPUS AI INC-CL A | 4.98% | 1.95% |
| IQVIA HOLDINGS INC | 6.00% | 0.75% |
| HINGE HEALTH INC-A | 3.24% | 0.70% |
| RECURSION PHARMACEUTICALS-A | 1.48% | 0.07% |
Only in HEAL
Show all 8 holdings
| VEEVA SYSTEMS INC-CLASS A | 6.13% |
| OSCAR HEALTH INC - CLASS A | 5.62% |
| PRO MEDICUS LTD | 4.98% |
| GE HEALTHCARE TECHNOLOGY | 4.66% |
| DEXCOM INC | 4.51% |
| RESMED INC | 4.00% |
| KONINKLIJKE PHILIPS NV | 3.94% |
| WAYSTAR HOLDING CORP | 3.83% |
Only in HELX
Show all 8 holdings
| GUARDANT HEALTH INC | 9.09% |
| NATERA INC | 7.46% |
| KRYSTAL BIOTECH INC | 6.33% |
| LIGAND PHARMACEUTICALS INC | 4.62% |
| ADAPTIVE BIOTECHNOLOGIES CORP | 3.99% |
| UNITED THERAPEUTICS CORP | 3.51% |
| BRIDGEBIO PHARMA INC | 3.50% |
| ELI LILLY & COMPANY | 2.95% |
Side by side
Open the table
| Fund | Global X HealthTech ETF · Holds 39 stocks in healthcare innovation and GLP-1, 27% of its weight in S&P 500 companies | Franklin Genomic Advancements ETF · Holds 61 stocks in healthcare innovation and GLP-1, 15% of its weight in S&P 500 companies |
| Issuer | Global X | Franklin |
| Theme | Healthcare innovation and GLP-1 | Healthcare innovation and GLP-1 |
| In the S&P 500 | 27.0% | 14.9% |
| Active share vs the S&P 500 | 99.6% | 97.2% |
| In the Nasdaq-100 | 7.9% | 7.5% |
| Holdings | 39 | 61 |
| Top ten, share of the fund | 48.6% | 47.1% |
| Expense ratio | 0.50% | 0.50% |
| Fee for the differing part | 0.50% | 0.51% |
| Total return, 1 year | +0.2% | +22.6% |
| vs its benchmark | not measured | not measured |
| Below its high | −55.5% | −26.5% |
| Net assets, HEAL as of Nov 11, 2026 and HELX as of Nov 12, 2026 | $38m | $34m |
As of Nov 13, 2026. Source: ETFIQ.
Window by window
Open the table
| 3 months | +2.9% | +5.0% |
|---|---|---|
| 6 months | +24.6% | +29.7% |
| 1 year | +0.2% | +22.6% |
| 3 years | +15.7% | +57.1% |
| Since launch (Not the same days: HEAL Jul 2020 · HELX Feb 2020) | −35.3% | +78.8% |
About HEAL
By weight, 27% of HEAL's portfolio is stocks that are also in the S&P 500; its active share against the S&P 500 is 100%. The top ten holdings are 49% of the fund across 39 positions, as published by its issuer for Nov 11, 2026.
More
Over the year to Nov 13, 2026 the fund returned +0.2% with distributions reinvested. It sits 55.5% below its all-time high of Feb 12, 2021.
About HELX
By weight, 15% of HELX's portfolio is stocks that are also in the S&P 500; its active share against the S&P 500 is 97%. The top ten holdings are 47% of the fund across 61 positions, as filed for Jun 30, 2026.
More
Over the year to Nov 13, 2026 the fund returned +22.6% with distributions reinvested. It sits 26.5% below its all-time high of Sep 7, 2021.
3% of the two portfolios are the same securities at the same weight.
Questions people ask
Do HEAL and HELX hold the same stocks?
By their latest filings, 3% of their books are the same securities at the same weight. Overlap is the sum of the smaller weight of every security they share.
Other comparisons
Sources
More
Links are sources, not endorsements. A comparison is not a recommendation.
Copy and cite
Cite this pageCitation, APA and Markdown
ETFIQ, HEAL against HELX, data as of Nov 13, 2026. https://etfiq.com/compare/themes/heal-vs-helx
ETFIQ. (Nov 13, 2026). HEAL against HELX. Retrieved from https://etfiq.com/compare/themes/heal-vs-helx
[HEAL against HELX (ETFIQ, Nov 13, 2026)](https://etfiq.com/compare/themes/heal-vs-helx)
Free to use with attribution for data ETFIQ computes; issuer data stays under its owner's terms.